What is Butterfly Network?
Butterfly Network, Inc. is at the forefront of revolutionizing medical imaging by developing, manufacturing, and commercializing advanced ultrasound solutions. Their flagship product, the Butterfly iQ series, offers a handheld, single-probe whole-body ultrasound system that integrates seamlessly with smartphones, tablets, and hospital computer systems. This technology democratizes access to high-quality diagnostic imaging, making it more portable and accessible for healthcare professionals across various settings, including a specialized version for veterinarians. The company's commitment to innovation positions it as a key player in the digital health and medical device industry.
How much funding has Butterfly Network raised?
Butterfly Network has raised a total of $352M across 3 funding rounds:
Private Equity
$100M
Unspecified
$250M
Debt
$2M
Private Equity (2014): $100M with participation from Aeris Capital AG
Unspecified (2018): $250M led by Fosun Pharma, Fidelity, and Bill & Melinda Gates Foundation
Debt (2020): $2M supported by PPP
Key Investors in Butterfly Network
Aeris Capital AG
Aeris Capital AG is an investment banking firm based in Zurich, Switzerland, likely focusing on strategic capital allocation and growth financing for technology-driven companies.
Fosun Pharma
Fosun Pharma, a Shanghai-based pharmaceutical company, brings significant expertise in healthcare research, development, and manufacturing, potentially aiding Butterfly Network's market access and product integration within the pharmaceutical ecosystem.
Fidelity
Fidelity Investments, a global financial services provider, offers extensive investment resources and capital, likely supporting Butterfly Network's scaling operations and long-term strategic objectives.
What's next for Butterfly Network?
The recent major enterprise-level funding and strategic investment indicate that Butterfly Network is poised for significant expansion and further technological advancement. This capital infusion is likely to accelerate product development, enhance manufacturing capabilities, and broaden market penetration globally. The company's focus on making advanced ultrasound technology more accessible suggests a strategic push towards establishing a dominant presence in both human and veterinary medical imaging markets. Future developments may include expanding the iQ platform's applications and integrating AI-driven diagnostic support.
See full Butterfly Network company page
